<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01378767</url>
  </required_header>
  <id_info>
    <org_study_id>110184</org_study_id>
    <nct_id>NCT01378767</nct_id>
  </id_info>
  <brief_title>Health Benefits of a 21-day Daniel Fast</brief_title>
  <official_title>Biochemical, Hemodynamic, and Anthropometric Effects of a 21-day Daniel Fast in Men and Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Memphis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Memphis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesized that individuals supplementing with krill oil capsules (two
      grams per day) would experience enhanced improvements in health-related variables during a
      21-day Daniel Fast.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the main purposes of the this investigation was to determine if krill oil
      supplementation (two grams per day for 21 days) enhances the effects of a 21-day Daniel Fast,
      particularly in regards to blood lipids and lipid peroxidation. The investigators were also
      interested in determining if adiponectin and/or resistin change in response to the fast, as
      these adipokines could potentially mediate the favorable glucoregulatory changes the
      investigators observed in our initial investigation of a 21-day Daniel Fast. Finally, the
      investigators sought to determine the changes in macronutrient and micronutrient intake
      during a Daniel Fast, and how these dietary changes affect our selected hemodynamic,
      anthropometric, blood lipid, glucoregulatory, oxidative stress, inflammatory, renal, and
      hepatic biomarkers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Lipids</measure>
    <time_frame>Change from baseline at 3 weeks</time_frame>
    <description>Total Cholesterol, LDL-C, HDL-C, VLDL-C, Triglyerides</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucoregulatory markers</measure>
    <time_frame>Change from baseline at 3 weeks</time_frame>
    <description>Blood glucose, blood insulin, Serum resistin, serum adiponectin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Markers of Oxidative Stress and Antioxidant Status</measure>
    <time_frame>Change from baseline at 3 weeks</time_frame>
    <description>Plasma malondialdehyde, plasma hydrogen peroxide, plasma nitrate/nitrite, Trolox Equivalent Antioxidant Capacity (measured in serum)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Change from baseline at 3 weeks</time_frame>
    <description>Systolic blood pressure, diastolic blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>Change from baseline at 3 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anthropometric Variables</measure>
    <time_frame>Change from baseline at 3 weeks</time_frame>
    <description>bodyweight, body mass index, waist circumference, hip circumference, body fat percentage, fat mass, fat free mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic Panel</measure>
    <time_frame>Change from baseline at 3 weeks</time_frame>
    <description>Blood urea nitrogen, creatinine, sodium, potassium, carbon dioxide, calcium, protein, albumin, globulin, bilirubin, alkaline phosphatase, aspartate transaminase, alanine transaminase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete Blood Count</measure>
    <time_frame>Change from baseline at 3 weeks</time_frame>
    <description>White blood cells, red blood cells, hemoglobin, hematocrit, mean cell volume, mean cell hemoglobin, mean corpuscular hemoglobin concentration, red blood cell distribution width, platelets, neutrophils, lymphocytes, monocytes, eosinophils, basophils</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Effects of Krill Oil on Human Health</condition>
  <arm_group>
    <arm_group_label>Krill oil capsules</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two grams per day daily for 21 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coconut oil capsules</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two grams per day for 21 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Krill oil supplementation</intervention_name>
    <description>During a 21-day Daniel Fast, group one supplemented with krill oil capsules (two grams per day) while group two supplemented with a placebo (coconut oil capsules at two grams per day).</description>
    <arm_group_label>Krill oil capsules</arm_group_label>
    <arm_group_label>Coconut oil capsules</arm_group_label>
    <other_name>Now Foods Neptune Krill Oil, 1000 mg- 60 Soft Gels</other_name>
    <other_name>Brand NOW</other_name>
    <other_name>Part Numbers 14431, 1627, 82048, NOW-01627, NWF-16270, NWF622</other_name>
    <other_name>UPC 733739016270</other_name>
    <other_name>Now Foods Coconut Oil, 1000 mg- 120 Soft Gels</other_name>
    <other_name>Part Numbers 091363-2, 1718, 18918, 24230, 5933510, 6485, 71668, 806542, NWF-17185, NWF119</other_name>
    <other_name>UPC 733739017185</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be 18 years of age or older.

          -  Must be willing to partake in a vegan diet for 21 days.

          -  Must be willing to consume either krill oil or coconut oil capsules (assigned
             randomly).

        Exclusion Criteria:

          -  Smokers

          -  regular consumption of antioxidant supplements

          -  women who were pregnant or seeking to become pregnant

          -  poor veins (veins that made it difficult to successfully obtain a blood draw - this
             was determined via a visual inspection)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard J Bloomer, Doctorate</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Memphis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiorespiratory/Metabolic Laboratory</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2011</study_first_submitted>
  <study_first_submitted_qc>June 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2011</study_first_posted>
  <last_update_submitted>June 20, 2011</last_update_submitted>
  <last_update_submitted_qc>June 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Richard Bloomer</name_title>
    <organization>University of Memphis</organization>
  </responsible_party>
  <keyword>Dietary restriction</keyword>
  <keyword>oxidative stress</keyword>
  <keyword>fasting</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

